With $100M Fund, NYC Wants A Bite Of The Biotech Apple
This article was originally published in Start Up
Executive Summary
The city and three industry giants are looking for VCs to run a new early-stage fund and match their $50 million. To sweeten the pot for new companies, some of the cash will be non-dilutive.
You may also be interested in...
GE’s Health Care Venture Adventure
GE’s healthymagination has evolved from an initiative focused on marketing, brand, and thought leadership activities into a significant, internally integrated corporate venture function around health care. But whether nimble, out-of-the-box thinking and a VC-like function can thrive inside a massive organization remains to be seen.
AAVLife: Another Gene Therapy Effort To Treat Friedreich's Ataxia
With the launch of AAVLife, Versant Ventures adds to its gene therapy portfolio, and people with Friedreich's ataxia can look to another program that takes aim at the rare inherited disease.
With AAVLife Debut, Another Gene Therapy Effort To Treat Friedreich's Ataxia
With the launch of AAVLife, Versant Ventures adds to its gene therapy portfolio, and people with Friedreich's ataxia can look to another program that takes aim at the rare inherited disease.